InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,447.87
(
0.00%
)
US TECH 100
19,037.60
(
0.42%
)
Dow Jones
39,411.21
(
0.00%
)
Brent Oil
84.98
(
-0.35%
)
Bitcoin
61,123.58
(
1.42%
)

Replies to post #212923 on Biotech Values

Replies to #212923 on Biotech Values

bladerunner1717

09/23/17 10:07 PM

#213813 RE: DewDiligence #212923

re: GEMP

Dew,

The company now plans to take the drug into a Phase III in early 2018. Do you (or PGS) see any hope of success?


Bladerunner

DewDiligence

01/31/18 4:38 PM

#216976 RE: DewDiligence #212923

GEMP expands NAFLD/NASH program to include pediatric NAFLD:

https://globenewswire.com/news-release/2018/01/31/1329623/0/en/Gemphire-Announces-Initiation-of-Phase-2a-Clinical-Trial-of-Gemcabene-in-Pediatric-Non-Alcoholic-Fatty-Liver-Disease-NAFLD.html